Opens in a new tab
Who Answers
Who Answers
DRS helpline phone number
Who Answers?

Calls to the website’s main helpline are answered by Wert Inc., a call center that specializes in helping individuals and families across the United States find resources for substance use disorder.

Addicted.org and Wert Inc. do not own any rehab or addiction services. This means our helpline can provide completely independent and unbiased advice to help you find the rehab service most suitable for you or your loved one.

Please note that if you are calling from California, your call will be answered by Alli Intervention, an intervention service based in California. However, when calling the helpline, you are under no obligation to use any of their services.

Our helpline comes at no cost to the caller and offers complete confidentiality.

You can also browse our comprehensive list of addiction treatments by state by visiting our homepage. Don’t hesitate to reach out by calling our helpline or filling out our contact form if you need help finding the right rehab center or detox program. However, if you believe you have a medical emergency, you should immediately call 911.

For more information, visit our What Happens When You Call Our Helpline page.

Home › Articles › Addiction Resources › Heroin Addiction Resources › Heroin Statistics & Data: Use Trends, Overdose Deaths, and Demographics

Heroin Statistics & Data: Use Trends, Overdose Deaths, and Demographics

Heroin’s place in the overdose picture in the United States has shifted twice. The Centers for Disease Control and Prevention (CDC) describes a second wave of the overdose epidemic that began in 2010, with rapid increases in deaths involving heroin, and a third that began in 2013, with substantial increases in deaths involving synthetic opioids, particularly illegally made fentanyl. Heroin has not been at the center of the crisis since.

Both heroin use and heroin overdose deaths have been declining recently, and so have overdose deaths overall. The sections below put figures to that, and to who is using heroin and who is dying from it.

A falling number is not the same as a smaller risk. Fewer people are using heroin and fewer are dying from it, but what is sold as heroin today is often mixed with illicitly manufactured fentanyl, which cannot be seen, tasted, or smelled. For anyone using it, that means a single dose can carry far more than expected.

Every number on this page carries a year, because these figures have moved quickly and a heroin statistic without a date attached is close to useless.

How Many People Use Heroin?

According to the 2024 National Survey on Drug Use and Health (NSDUH), about 556,000 people aged 12 or older in the United States used heroin in the past year. That is 0.2% of the US population aged 12 and older, or roughly two people in every 1,000. The same figure for 2023 was 660,000.

Use is concentrated among older adults. Adults 26 and older accounted for 495,000 of the 2024 total, which is 0.2% of all US adults in that age group. Young adults 18 to 25 accounted for 51,000, or 0.1% of all 18 to 25 year olds, and adolescents 12 to 17 for 10,000, under 0.1% of all 12 to 17 year olds.

These figures leave some people out, by design rather than by error. The survey covers residents of households and people in noninstitutional group settings such as shelters, boarding houses, college dormitories, and halfway houses. It excludes people with no fixed address, including people experiencing homelessness who are not in shelters, military personnel on active duty, and residents of institutional group settings such as jails, nursing homes, and long-term care facilities. Nobody in those groups appears in the count.

Heroin Overdose Deaths: The Historical Arc

Heroin overdose deaths are reported as a rate per 100,000 people, which is what makes separate years comparable. Three data briefs from the National Center for Health Statistics (NCHS) trace the whole arc, covering 1999 to 2018, 2002 to 2022, and 2023 to 2024.

  • 0.7 in 1999, rising to 1.0 in 2010
  • 4.9 in 2016, and 4.9 again in 2017, the high point of the series
  • 4.7 in 2018
  • 2.8 in 2021, then 1.8 in 2022, a decrease of 35.7% in a single year
  • 1.2 in 2023, then 0.8 in 2024, a decrease of 33.3%

NCHS describes the pattern as increasing from 2002 to 2016, holding steady from 2016 to 2020, then declining significantly from 2020 to 2022. These briefs do not give separate figures for 2019 and 2020.

What changed in between was the drug supply. The CDC dates the third wave of the overdose epidemic to 2013, when deaths involving synthetic opioids, mainly illegally made fentanyl, began rising sharply. By 2023, about 69% of all drug overdose deaths involved synthetic opioids, while heroin was involved in nearly 4,000, about 4% of drug overdose deaths and 5% of opioid overdose deaths that year.

Overall Drug Overdose Trends: The Bigger Picture

Heroin’s decline happened inside a much larger crisis, one driven by synthetic opioids, and that crisis has now turned as well. NCHS reports:

  • 79,384 drug overdose deaths in 2024, an age-adjusted rate of 23.1 per 100,000
  • A 26.2% drop in that rate from 31.3 in 2023, the largest percentage drop across the 2014 to 2024 period
  • A rate that had climbed from 14.7 in 2014 to 32.6 in 2022 before it turned
  • A 35.6% decrease in the rate involving synthetic opioids other than methadone, mainly fentanyl, from 22.2 to 14.3
  • Declines for every age group and every race and Hispanic-origin group, with the largest among people aged 15 to 24, down 37.0%, and among Black non-Hispanic people, down 30.9%

Even after that drop, drug overdoses remain one of the leading causes of injury death in adults.

Demographic Patterns: Who Is Most Affected

The most current demographic breakdown comes from the NCHS brief, and it covers all drug overdose deaths rather than heroin specifically. Heroin accounts for a small share of that total, so these figures describe the shape of the crisis a person using heroin is inside, not a profile of heroin deaths.

By age:

  • The rate was highest among adults 35 to 44 in both years, 60.8 per 100,000 in 2023 and 44.2 in 2024
  • The largest decline was among people 15 to 24, down 37.0%, from 13.5 to 8.5
  • The smallest decline was among adults 65 and older, from 14.7 to 13.4

By sex:

  • In 2024 the rate was 32.2 per 100,000 for males and 14.1 for females, more than twice as high for men
  • For both men and women, the drop from 2023 to 2024 was the largest annual decrease across the 2014 to 2024 period

By race and ethnicity:

  • The rate was highest for American Indian and Alaska Native non-Hispanic people in both years, 65.0 in 2023 and 51.6 in 2024
  • It was lowest for Asian non-Hispanic people, 5.1 and 4.4
  • The largest decline was for Black non-Hispanic people, down 30.9%, from 48.9 to 33.8
  • Rates fell for every race and Hispanic-origin group

One caveat the brief raises itself: race and Hispanic origin are misclassified on some death certificates, which understates rates by about 3% for Asian and Hispanic people and by about 34% for American Indian and Alaska Native people. The figures above are not adjusted for that, so the real gap between the highest and lowest groups is likely wider than it looks.

The Heroin-to-Fentanyl Transition in the Data

A heroin statistic rarely describes heroin alone. NCHS explains that one death can be counted in more than one drug category, because overdose deaths often involve several drugs at once. Its own example is a death involving both fentanyl and cocaine, which is counted in the synthetic opioid rate and again in the cocaine rate. The same applies to heroin. A death involving heroin and fentanyl appears under both.

There is a second wrinkle when comparing years. NCHS notes that the share of overdose deaths where the specific drugs involved were identified rose from 81% in 2014 to 96% in 2024, so the early figures in any drug-specific series rest on less complete information than the recent ones.

Those two things change how the heroin decline should be read, and what follows is our reading of the data rather than a finding any of these sources states. The fall in heroin deaths looks less like heroin becoming less dangerous and more like a change in what people are actually taking. What is sold as heroin now often contains fentanyl, and a death that involves both can end up recorded under the fentanyl heading rather than the heroin one. For someone still using, that is a change in the paperwork, not a change in the risk.

Treatment Access and the Treatment Gap

The gap between needing treatment and getting it is wide. According to the 2024 NSDUH, 52.6 million people aged 12 or older needed substance use treatment in the past year, 18.2% of that population. Of those, 10.2 million received it, or 19.3%, about one in five.

The gap is widest among people who met the criteria for a substance use disorder. Of the 48.4 million people with one in 2024, 12.3% received treatment, and 87.7%, or 42.4 million people, did not.

For opioids specifically, 4.8 million people aged 12 or older had an opioid use disorder in the past year, and 17.0% of them, or 818,000 people, received medication for it. The National Institute on Drug Abuse (NIDA) reports the same thing as fewer than one in five, and notes that people with opioid use disorder treated with methadone or buprenorphine are less likely to die or to have an overdose than those who do not receive treatment.

Cost and availability are not the whole story. Among adults with a substance use disorder who did not receive treatment, 95.6% did not think they needed it. Among the small share who did perceive a need, the most common reasons for not getting treatment were thinking they should be able to handle their use on their own, at 75.5%, not being ready to start treatment, at 65.0%, and not being ready to stop or cut back, at 59.5%. Cost came next, at 45.3%, followed by worry about what people would think or say, at 43.2%.

What the Numbers Can and Cannot Tell You

The direction in this data is real. Fewer people are using heroin, fewer are dying from it, and overdose deaths overall have fallen further and faster than at any point in the past decade.

What the numbers cannot tell you is whether any of that makes a given night safer for one person. A national rate falling by a third says nothing about what is in a particular dose, and fentanyl in the supply is the reason those two questions have come apart.

Two other limits are worth carrying away. Death records and household surveys both lag, so even the most current figures here describe a year that has already closed. And the surveys do not reach everyone, including people with no fixed address and people in jails and prisons, who are missing from the counts rather than absent from the problem.

If the numbers brought you here, the one worth sitting with is not the decline. It is how many people with a substance use disorder went untreated last year, and how many of them did not believe they needed treatment. That gap is not closed by a trend line.

Continue Reading